1. Home/
  2. Compounds/
  3. tretinoin:navitoclax (4:1 mol/mol)

tretinoin:navitoclax (4:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2tretinoin:navitoclax (4:1 mol/mol)
PharmacoGx tretinoin:navitoclax (4:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to tretinoin:navitoclax (4:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA NBPF9 CTRPv2 pan-cancer AAC -0.16 6e-06
mRNA METAP2 CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA PSMB6 CTRPv2 pan-cancer AAC -0.16 4e-06
mRNA LSM10 CTRPv2 pan-cancer AAC -0.16 7e-06
mRNA SHCBP1 CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA KCNN3 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA EIF5A CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA CCDC102A CTRPv2 pan-cancer AAC -0.16 3e-06
mRNA NUGGC CTRPv2 pan-cancer AAC -0.16 5e-06
mRNA MCL1 CTRPv2 pan-cancer AAC -0.16 2e-06
Download CSV